Fewer than half of patients with multiple sclerosis respond to interferon-beta, one of the most widely prescribed therapies. The discovery that different subtypes of T cells may be involved in disease development in each affected individual suggests that it may be possible to predict therapeutic success by determining a patient's cytokine profile (pages 406-412).
机构:
Univ Calif San Francisco, Dept Neurol, MS Ctr, San Francisco, CA 94115 USAUniv Calif San Francisco, Dept Neurol, MS Ctr, San Francisco, CA 94115 USA
机构:
Fdn Don C Gnocchi, IRCCS Santa Maria Nascente, Unit Motor Neurorehabil, Multiple Sclerosis Ctr, Milan, ItalyFdn Don C Gnocchi, IRCCS Santa Maria Nascente, Unit Motor Neurorehabil, Multiple Sclerosis Ctr, Milan, Italy
Tavazzi, Eleonora
Rovaris, Marco
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Don C Gnocchi, IRCCS Santa Maria Nascente, Unit Motor Neurorehabil, Multiple Sclerosis Ctr, Milan, ItalyFdn Don C Gnocchi, IRCCS Santa Maria Nascente, Unit Motor Neurorehabil, Multiple Sclerosis Ctr, Milan, Italy
Rovaris, Marco
La Mantia, Loredana
论文数: 0引用数: 0
h-index: 0
机构:
Fdn Don C Gnocchi, IRCCS Santa Maria Nascente, Unit Motor Neurorehabil, Multiple Sclerosis Ctr, Milan, ItalyFdn Don C Gnocchi, IRCCS Santa Maria Nascente, Unit Motor Neurorehabil, Multiple Sclerosis Ctr, Milan, Italy